- Supported exchanges /
- F /
- 7UX.F
SPAGO NANOMEDICAL AB (7UX F) stock market data APIs
Spago Nanomedical AB (publ), a clinical phase nanomedicine company, engages in the development of nanomedicines for cancer diagnostics and treatment primarily in Sweden. Its products include SpagoPix (SN132D), an MRI contrast agent, which is under Phase I development stage for the treatment of breast cancer, and under Phase II development stage for the treatment liver and pancreas cancer, as well as offers Tumorad (SN201), a radionuclide therapy for treatment of advanced and metastatic cancer, under Preclinical development stage. The company was formerly known as Spago Imaging AB (publ) and changed its name to Spago Nanomedical AB (publ) in May 2014. Spago Nanomedical AB (publ) was incorporated in 1999 and is based in Lund, Sweden.
SPAGO NANOMEDICAL AB Financial Data Overview
| 0.015 | |
| 0.0166 | |
| - | |
| 0.0182 | |
| 0.015 | |
| 0.0118-0.0328 | |
| 5 297 K | |
| 348 M | |
| 6 276 K | |
| 2.115 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
SPAGO NANOMEDICAL AB Fundamental Data is available in our Financial Data APIs
- Net Revenue 6 276 K
- EBITDA -33 171 000
- Earnings Per Share -0.02
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get SPAGO NANOMEDICAL AB Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get SPAGO NANOMEDICAL AB End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
